Rousseau G - Search Results

1

Diltiazem at reperfusion reduces neutrophil accumulation and infarct size in dogs with ischaemic myocardium.

Rousseau G, St-Jean G, Latour JG, Merhi Y, Nattel S, Waters D. Rousseau G, et al. Cardiovasc Res. 1991 Apr;25(4):319-29. doi: 10.1093/cvr/25.4.319. Cardiovasc Res. 1991. PMID: 1884391

2

Effect of coronary reperfusion on technetium-99m methoxyisobutylisonitrile uptake by viable and necrotic myocardium in the dog.

Merhi Y, Latour JG, Arsenault A, Rousseau G. Merhi Y, et al. Among authors: rousseau g. Eur J Nucl Med. 1992;19(7):503-10. doi: 10.1007/BF00185856. Eur J Nucl Med. 1992. PMID: 1644107

3

Spacial and temporal profiles of neutrophil accumulation in the reperfused ischemic myocardium.

de Lorgeril M, Rousseau G, Basmadjian A, St-Jean G, Tran DC, Latour JG. de Lorgeril M, et al. Among authors: rousseau g. Am J Cardiovasc Pathol. 1990;3(2):143-54. Am J Cardiovasc Pathol. 1990. PMID: 2264987

4

Influence of reflow ventricular fibrillation and electrical defibrillation on infarct size in a canine preparation of myocardial infarction.

de Lorgeril M, Basmadjian A, Clément R, Rousseau G, Latour JG. de Lorgeril M, et al. Among authors: rousseau g. Cardiovasc Res. 1990 Feb;24(2):151-5. doi: 10.1093/cvr/24.2.151. Cardiovasc Res. 1990. PMID: 2328519

5

Influence of leukopenia on collateral flow, reperfusion flow, reflow ventricular fibrillation, and infarct size in dogs.

de Lorgeril M, Basmadjian A, Lavallée M, Clément R, Millette D, Rousseau G, Latour JG. de Lorgeril M, et al. Among authors: rousseau g. Am Heart J. 1989 Mar;117(3):523-32. doi: 10.1016/0002-8703(89)90724-2. Am Heart J. 1989. PMID: 2919531

6

Lignocaine in experimental myocardial infarction: failure to prevent neutrophil accumulation and ventricular fibrillation and to reduce infarct size.

de Lorgeril M, Rousseau G, Basmadjian A, Latour JG. de Lorgeril M, et al. Among authors: rousseau g. Cardiovasc Res. 1988 Jun;22(6):439-46. doi: 10.1093/cvr/22.6.439. Cardiovasc Res. 1988. PMID: 3224356

7

Sustained myocardial protection by clentiazem (TA-3090) after a 90-minute coronary occlusion and 72 hours of reperfusion in dogs with collateral flow.

Rousseau G, Provost P, Latour JG. Rousseau G, et al. J Cardiovasc Pharmacol. 1993 Aug;22(2):264-72. doi: 10.1097/00005344-199308000-00015. J Cardiovasc Pharmacol. 1993. PMID: 7692168

8

Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.

Rousseau G, Provost P, Tran D, Caillé G, Latour JG. Rousseau G, et al. J Pharmacol Exp Ther. 1994 Mar;268(3):1252-60. J Pharmacol Exp Ther. 1994. PMID: 8138938

9

Importance of platelets in myocardial injury after reperfusion in the presence of residual coronary stenosis in dogs.

Rousseau G, Hébert D, Libersan D, Khalil A, St-Jean G, Latour JG. Rousseau G, et al. Am Heart J. 1993 Jun;125(6):1553-63. doi: 10.1016/0002-8703(93)90740-z. Am Heart J. 1993. PMID: 8498293

10

Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets.

Libersan D, Rousseau G, Merhi Y. Libersan D, et al. Among authors: rousseau g. Thromb Haemost. 2003 Feb;89(2):310-7. Thromb Haemost. 2003. PMID: 12574812

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

556 results

Search Page

Filters